-
1
-
-
0031571676
-
-
Gurtu, V.; Kain, S. R.; Zhang, G. Anal. Biochem. 1997, 251, 98-102.
-
(1997)
Anal. Biochem.
, vol.251
, pp. 98-102
-
-
Gurtu, V.1
Kain, S.R.2
Zhang, G.3
-
2
-
-
85037962847
-
-
Molecular Probes, Inc., Eugene, OR, USA
-
Molecular Probes, Inc., Eugene, OR, USA.
-
-
-
-
5
-
-
15844405637
-
-
Schmitt, W.; Zanotti, G.; Wieland, T.; Kessler, H. J. Am. Chem. Soc. 1996, 118, 4380-4387.
-
(1996)
J. Am. Chem. Soc.
, vol.118
, pp. 4380-4387
-
-
Schmitt, W.1
Zanotti, G.2
Wieland, T.3
Kessler, H.4
-
6
-
-
85037965567
-
-
Peptide 3 was purchased from BioMol Research Laboratories, Plymouth Meeting, PA, USA
-
Peptide 3 was purchased from BioMol Research Laboratories, Plymouth Meeting, PA, USA.
-
-
-
-
7
-
-
85037959508
-
-
N-Tr-6-Aminohexanoic acid was prepared by the reaction of methyl 6-aminohexanoate hydrochloride with Tr-chloride (DMF, DIEA) followed by saponification. The corresponding mixed anhydride was prepared by treating the protected amino acid with IBCF in the presence of NMM in THF at -10°C
-
N-Tr-6-Aminohexanoic acid was prepared by the reaction of methyl 6-aminohexanoate hydrochloride with Tr-chloride (DMF, DIEA) followed by saponification. The corresponding mixed anhydride was prepared by treating the protected amino acid with IBCF in the presence of NMM in THF at -10°C.
-
-
-
-
8
-
-
31644440186
-
-
The preparation of a cyclic peptide employing a 4-nitrophenyl ester has been reported
-
The preparation of a cyclic peptide employing a 4-nitrophenyl ester has been reported. Studer, R. O.; Lergier, W. Helv. Chim. Acta 1965, 460-470.
-
(1965)
Helv. Chim. Acta
, pp. 460-470
-
-
Studer, R.O.1
Lergier, W.2
-
9
-
-
85037964646
-
-
The mass spectral analysis was performed by Mass Consortium Corp., San Diego, CA, USA
-
The mass spectral analysis was performed by Mass Consortium Corp., San Diego, CA, USA.
-
-
-
-
10
-
-
85037970148
-
-
2O) δ 0.97-1.80 (m, 6H), 1.21 (t, J=7 Hz, 27H), 1.36-2.78 (m, 28H), 2.97 (q, J=7 Hz, 18H), 4.06 (t, J=3 Hz, 1H), 4.38 (bs, 1H), 4.68-4.80 (m, 1H), 6.64 (d, J=9 Hz, 1H), 6.65 (d, J=9 Hz, 1H), 7.11 (d, J=9 Hz, 1H), 7.23 (d, J=8 Hz, 1H), 7.50-7.83 (m, 4H), 7.88-7.93 (m, 1H), 8.02 (d, J=8 Hz, 1H)
-
2O) δ 0.97-1.80 (m, 6H), 1.21 (t, J=7 Hz, 27H), 1.36-2.78 (m, 28H), 2.97 (q, J=7 Hz, 18H), 4.06 (t, J=3 Hz, 1H), 4.38 (bs, 1H), 4.68-4.80 (m, 1H), 6.64 (d, J=9 Hz, 1H), 6.65 (d, J=9 Hz, 1H), 7.11 (d, J=9 Hz, 1H), 7.23 (d, J=8 Hz, 1H), 7.50-7.83 (m, 4H), 7.88-7.93 (m, 1H), 8.02 (d, J=8 Hz, 1H).
-
-
-
-
11
-
-
85037951063
-
-
Assay conditions: [8]=10 μM; Recombinant caspase 3 was prepared in bacterial cell cultures and crude preparations were diluted to give a measurable fluorescent signal. An 1:50000 dilution gave about 1300 counts/h over 3 h. An 1:1000 dilution gave about 5000 counts/h over 12 h. Virtually no fluorescence was detected in the absence of recombinant caspase 3
-
Assay conditions: [8]=10 μM; Recombinant caspase 3 was prepared in bacterial cell cultures and crude preparations were diluted to give a measurable fluorescent signal. An 1:50000 dilution gave about 1300 counts/h over 3 h. An 1:1000 dilution gave about 5000 counts/h over 12 h. Virtually no fluorescence was detected in the absence of recombinant caspase 3.
-
-
-
-
12
-
-
0032484008
-
-
Experiments performed as described in Ref 10 but with the addition of Ac-DEVD-CHO (10 μM)
-
Garcia-Calvo, M.; Peterson, E. P.; Leiting, B.; Ruel, R.; Nicholson, D. W.; Thornberry, N. A. J. Biol. Chem. 1998, 273, 32608-32613. Experiments performed as described in Ref 10 but with the addition of Ac-DEVD-CHO (10 μM).
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 32608-32613
-
-
Garcia-Calvo, M.1
Peterson, E.P.2
Leiting, B.3
Ruel, R.4
Nicholson, D.W.5
Thornberry, N.A.6
-
13
-
-
85037960622
-
-
Assay conditions: NIH3T3 (mouse endothelial) and D5 (mouse melanoma) cell lines (ATCC, Rockville, MD), induced for apoptosis by treatment with etoposide (50 μg/mL in RPMI1640 media+10% CS for 18 h), with [8]=50 μM (for 1 h) showed significant and cell-specific labeling. These same cell lines were also stained with the fluorescent caspase 3 cell permeable inhibitor FITC-VAD-FMK (Promega Corp., Madison, WI) to verify apoptosis induction. Non-induced cell lines showed little or no detectable labeling under identical conditions
-
Assay conditions: NIH3T3 (mouse endothelial) and D5 (mouse melanoma) cell lines (ATCC, Rockville, MD), induced for apoptosis by treatment with etoposide (50 μg/mL in RPMI1640 media+10% CS for 18 h), with [8]=50 μM (for 1 h) showed significant and cell-specific labeling. These same cell lines were also stained with the fluorescent caspase 3 cell permeable inhibitor FITC-VAD-FMK (Promega Corp., Madison, WI) to verify apoptosis induction. Non-induced cell lines showed little or no detectable labeling under identical conditions.
-
-
-
|